1Perry CM, Scott LJ. Cefdinir: A review of its use in the management of mild-to-moderate bacterial infections. Drugs, 2004,64:1433-1464.
2David RJ, Guay, Pharm D. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin. Clin Therapics, 2002,24:473-489.
3David RP, Pharm D. Pharmacodynamics and Pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin. Pediatr Infect Dis J, 2000,19(Suppl):141-146.
5Power J, Gooch WM, Oddo LP. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefpro-zil, and azithromycin in pediatric patuents. Pediatr Infect Dis J, 2000,19(Suppl):174-180.
6Block SL, Kratzer J, Nemeth MA, et al. Five-day cefdinir course vs.ten-day cefprozil course for treatment of acute otitis media. Pediatr Infect Dis J, 2000,19(Suppl):147-152.
7Block SL, Hedrick JA, Nemeth MA, et al. Five-day twice daily therapy for acute otitis media: microbiologic and clinical efficacy. Pediatr Infect Dis J, 2000,19(Suppl):153-158.
8Block SL, McCarty JM, Hedrick JA, et al. Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of acute suppurative otitis media in children. Pediatr Infect Dis J, 2000,19(Suppl):159-165.
9Adler M, McDonald, Trustmann U. Cefdinir vs. amoxicillin/clavulanic acid in treatment of acute suppurative otitis media in children. Pediatr Infect Dis J, 2000,19(Suppl):166-170.
10Pichichero M, Gooch WM 3rd. Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis. Pediatr Infect Dis J, 2000,19(Suppl):171-173.
二级参考文献5
1Wise R, Andrews JM, Thornber D. Thein vitro activity of cefdinir , a new oral cephalosporin [J]. J Antimicrob Chemother,1991,28(2):239-248
2Shimada K, Shishido A,Tsunoo M. Phase Ⅰ study of cefdinir[J]. Chemotherapy,1989,37(Suppl 2):208-245
3Jones RN. In vitro antibacterial activity of oral cephalosporins[J]. Clin DrugInvest, 1995,9(Suppl 3):22-30
4Appelbaum PC. Cefdinir: a review of its antibacterial and therapeutic potential incommunity-acquired infections[J]. Clin Drug Invest, 1995,9(Suppl 3):54-64
5National Committee for Clinical Laboratory Standards. Documents M7: performancestandards for antimicrobial dilution susceptibility tests. Approval standards[S]. NCCLS,2000
